Abstract
The treatment of infectious diseases continues to face challenges such as drug resistance, systemic toxicity, and reduced therapeutic efficacy. Drug targeting strategies have emerged as a pivotal advancement to overcome these barriers by delivering therapeutics directly to the site of infection or pathogen. These approaches enhance drug bioavailability, minimize off-target effects, and improve patient outcomes. This article reviews various drug targeting techniques, including passive and active targeting, ligand-receptor interactions, and nanocarrier systems, with a special focus on bacterial, viral, fungal, and parasitic infections. It also discusses current challenges and future prospects for implementing targeted therapies in clinical settings.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Dr. Aisha Rahman (Author)